Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: CACI stock price vs CPRT: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CPRT's multiple
Needs CPRT P/E.
Implied fair value · at CACI's multiple
Needs CACI P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CACI FY 2026 (ended Jun 30, 2026) · CPRT FY 2025 (ended Jul 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 74% equity / 26% debt · EV / Revenue 1.94x · EV / EBITDA 17.07x
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 100% equity / -0% debt
CPRT carries the larger enterprise value at $31.11B against $18.54B; CACI trades on the lower EV / Revenue multiple (1.94x vs 6.70x); CPRT on the lower EV / EBITDA (14.78x vs 17.07x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
CACI INTERNATIONAL INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
COPART, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.11x
-0.01x
Net debt / EBITDA
Leverage against operating earnings
4.38x
—
Cash and equivalents
Liquid reserves on the balance sheet
$191.76M
—
Total debt
Interest-bearing obligations outstanding
$4.95B
-$104.58M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Science Applications International Corp
CACI vs SAIC
KBR, INC.
CACI vs KBR
Booz Allen Hamilton Holding Corp
CACI vs BAH
Leidos Holdings, Inc.
CACI vs LDOS
JACOBS SOLUTIONS INC.
CACI vs J
CARVANA CO.
CACI vs CVNA
CARMAX INC
CACI vs KMX
OPENLANE, Inc.
CACI vs KAR
AUTONATION, INC.
CACI vs AN
Tesla, Inc.
CACI vs TSLA
FORD MOTOR CO
CACI vs F
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
